Concepedia

Michael Pourdehnad

MP

Statistics

Publications

37

Citations

3.4K

H-Index

22

Active since

1999

Affiliations

Bristol-Myers Squibb (United States)(Current)

Hospital of the University of Pennsylvania

The University of Texas MD Anderson Cancer Center

Princess Margaret Cancer Centre

Dana-Farber Cancer Institute

Michael Pourdehnad is an author at Bristol-Myers Squibb (United States) specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

1999–2024

37

Publications

37

Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.

H. Zhuang, Michael Pourdehnad, E.S. Lambright et al. · PubMed · 2001 · 622 citations

The measurement of regional cerebral blood flow during the complex cognitive task of meditation: a preliminary SPECT study

Andrew B. Newberg, Abass Alavi, Michael J. Baime et al. · Psychiatry Research Neuroimaging · 2001 · 487 citations

, , +12

Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers

Michael Pourdehnad, Morgan Truitt, Imran Siddiqi et al. · Proceedings of the National Academy of Sciences · 2013 · 291 citations · Full text

, , +13

The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants.

H Zhuang, Paulo Schiavom Duarte, Michael Pourdehnad et al. · PubMed · 2001 · 239 citations

CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells

Christine Surka, Liqing Jin, Nathan Mbong et al. · Blood · 2020 · 208 citations · Full text

1–5 of 37